Robert E. Déziel
Nessuna posizione attualmente
Storia della carriera di Robert E. Déziel
Precedenti posizioni note di Robert E. Déziel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Neokimia, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
| Origenix Technologies, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 01/01/2003 | - |
Formazione di Robert E. Déziel
| University of Montréal | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 4 |
| Stati Uniti | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
| Neokimia, Inc. | Health Technology |
| Origenix Technologies, Inc. |
- Borsa valori
- Insiders
- Robert E. Déziel
- Esperienza
